In our study, utilizing the DepMap database, we investigated the effects of TUBA1C knockout on the phenotypes of kidney cancer cell lines and examined the relationship between TUBA1C mutations and the efficacy of anti-PD-L1 therapy. The gene discussed is CD274; the disease is kidney cancer.